e-learning
resources
Copenhagen 2005
Saturday 17.09.2005
PG15 - Therapeutic options for interstitial lung diseases in 2005
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Therapeutic options for sarcoidosis: old and new
R. P. Baughman (Cincinnati, United States of America)
Source:
Annual Congress 2005 - PG15 - Therapeutic options for interstitial lung diseases in 2005
Session:
PG15 - Therapeutic options for interstitial lung diseases in 2005
Session type:
Postgraduate Course
Number:
72
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. P. Baughman (Cincinnati, United States of America). Therapeutic options for sarcoidosis: old and new. Annual Congress 2005 - PG15 - Therapeutic options for interstitial lung diseases in 2005
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Standard therapy for sarcoidosis
Source: Annual Congress 2005 - Biological agents in the therapy of sarcoidosis
Year: 2005
Pharmacological treatment of severe, therapy-resistant asthma in children: what can we learn from where?
Source: Eur Respir J 2011; 38: 947-958
Year: 2011
Corticosteroid treatment in sarcoidosis
Source: Eur Respir J 2006; 28: 627-636
Year: 2006
Combined immunosuppressive therapy including anti-TNFα in a treatment of severe paediatric sarcoidosis – a case report
Source: Eur Respir J 2006; 28: Suppl. 50, 829s
Year: 2006
Biologic therapies in paediatric severe asthma
Source: ERS webinar 2020: Biologic therapies in paediatric severe asthma
Year: 2020
Idiopathic pulmonary fibrosis: efficacy of complex immunosuppressive therapy by cyclophosphamide and corticosteroids
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009
Glucocorticosteroid treatment in sarcoidosis: comparison of regimens
Source: Eur Respir J 2003; 22: Suppl. 45, 234s
Year: 2003
Comparative analysis of the efficacy of glucocorticosteroids and antimetabolite drugs in treatment of patients with pulmonary sarcoidosis
Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues
Year: 2019
Efficacy and safety of modified anti-tubercular treatment(ATT) regimens in treatment of tuberculosis(TB) in patients with underlying chronic liver disease(CLD)
Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline
Year: 2016
Methotrexate as a single agent for the treatment of patients with progressive pulmonary sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015
Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial
Source: Eur Respir J 2008; 31: 1189-1196
Year: 2008
Anti-inflammatory therapies in bronchiectasis
Source: Eur Respir Mon 2011; 52: 223-238
Year: 2011
Infliximab: An effective rescue therapy in refractory extra-pulmonary sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
What is the role of oral corticosteroids in the era of biologics in asthma?
Source: International Congress 2019 – State of the art session: Airway disease
Year: 2019
Current approaches to the prevention of tuberculosis in patients receiving immunosuppressants
Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Year: 2021
The response to combination therapy treatment regimens in severe/difficult-to-treat asthma
Source: Eur Respir J 2008; 32: 1237-1242
Year: 2008
Combination of pentoxifylline and steroids in sarcoidosis treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 269s
Year: 2005
Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab
Source: International Congress 2016 – Sarcoidosis
Year: 2016
The new approaches to the oral corticosteroid dosage decrease in patients with severe steroid-resistant bronchial asthma
Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept